首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Heterogeneous nuclear ribonudeoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells
【24h】

Heterogeneous nuclear ribonudeoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells

机译:异种核糖核蛋白L样(hnRNPLL)和延伸因子RNA聚合酶II,2(ELL2)是浆细胞中mRNA加工的调节剂

获取原文
获取原文并翻译 | 示例
           

摘要

B cells and plasma cells possess distinct RNA processing environments that respectively promote the expression of membrane-associated Ig by B cells versus the secretion of Ig by plasma cells. Through a combination of transcriptional profiling and screening using a lenti-viral short-hairpin RNA interference library, we show that both the splicing factor hnRNPLL and the transcription elongation factor ELL2 modulate the ratio of secreted versus membrane-encoding Ighg2b transcripts in MPC11 plasmacytoma cell lines. hnRNPLL and ELL2 are both highly expressed in primary plasma cells relative to B cells, but hnRNPLL binds Ighg2b mRNA transcripts and promotes an increase in levels of the membrane-encoding Ighg2b isoform at the expense of the secreted Ighg2b isoform, whereas ELL2 counteracts this effect and drives Ig secretion by increasing the frequency of the secreted Ighg2b isoform. As in T cells, hnRNPLL also alters the splicing pattern of mRNA encoding the adhesion receptor CD44, promoting exon inclusion, and decreasing the overall level of CD44 expression. Further characterization of ELL2-dependent transcription by RNA-Seq revealed that ~12% of transcripts expressed by plasma cells were differentially processed because of the activities of ELL2, including B-cell maturation antigen BCMA, a receptor with a defined role in plasma cell survival. Taken together, our data identify hnRNPLL and ELL2 as regulators of pre-mRNA processing in plasma cells.
机译:B细胞和浆细胞具有截然不同的RNA处理环境,分别促进了B细胞膜相关Ig的表达与浆细胞Ig的分泌。通过转录谱分析和使用慢病毒短发夹RNA干扰文库的筛选相结合,我们显示剪接因子hnRNPLL和转录延伸因子ELL2均能调节MPC11浆细胞瘤细胞系中分泌型和膜编码型Ighg2b转录本的比率。相对于B细胞,hnRNPLL和ELL2均在原浆细胞中高表达,但hnRNPLL结合Ighg2b mRNA转录物并促进膜编码Ighg2b同工型水平的增加,但以分泌的Ighg2b同工型为代价,而ELL2则抵消了这种作用并通过增加分泌的Ighg2b同工型的频率来驱动Ig分泌。像在T细胞中一样,hnRNPLL也会改变编码粘附受体CD44的mRNA的剪接模式,促进外显子包涵,并降低CD44表达的总体水平。 RNA-Seq对ELL2依赖性转录的进一步表征显示,由于ELL2的活性,包括B细胞成熟抗原BCMA(在血浆细胞存活中具有明确作用的受体)的活性,浆细胞表达的转录物约有12%被差异化处理。 。综上所述,我们的数据确定hnRNPLL和ELL2是浆细胞中mRNA预处理的调节因子。

著录项

  • 来源
  • 作者单位

    Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115;

    Department of Information and Computer Science, Aalto University School of Science, FI-00076 Aalto, Finland;

    Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;

    Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115;

    Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115,Department of Information and Computer Science, Aalto University School of Science, FI-00076 Aalto, Finland;

    National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894;

    National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894;

    Molecular and Systems Immunology and Stem Cell Biology, Turku Centre for Biotechnology, University of Turku and Abo Akademi University, FI-20520 Turku, Finland;

    Center for Cancer Research, Mouse Cancer Genetics Program, National Cancer Institute at Frederick, Frederick, MD, 21702;

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02215;

    Molecular and Systems Immunology and Stem Cell Biology, Turku Centre for Biotechnology, University of Turku and Abo Akademi University, FI-20520 Turku, Finland;

    Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115,Molecular and Systems Immunology and Stem Cell Biology, Turku Centre for Biotechnology, University of Turku and Abo Akademi University, FI-20520 Turku, Finland;

    Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115,Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037,Department of Pharmacology, University of California at San Diego, La Jolla, CA 92037,Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    immunoglobulin; mRNA splicing; transcriptional elongation; B cell maturation antigen;

    机译:免疫球蛋白mRNA剪接;转录延伸B细胞成熟抗原;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号